Tal Zaks

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

David A. Tuveson, Alice T. Shaw, Nicholas A. Willis et al. · Cancer Cell · 2004 · 816 citations · Full text

Medicine, Genetics, Oncology +14

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 739 citations

Life Sciences, Immunology, Oncology +14

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

Kapil Bahl, Joe J. Senn, Olga Yuzhakov et al. · Molecular Therapy · 2017 · 654 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt et al. · Science · 2021 · 599 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Robert Feldman, Rainard Fuhr, Igor Smolenov et al. · Vaccine · 2019 · 463 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17